Affiliation: University of Edinburgh

Following an undergraduate degree in Biotechnology from the Polytechnic University of Valencia, Dr. Carlos Martínez-Pérez gained an MSc in Molecular Medicine in Cranfield University, followed by a PhD in Molecular and Clinical Medicine (Pathology) in the University of Edinburgh, working on a SULSA BioSkape industrial collaboration project focused on pre-clinical drug development in breast and ovarian cancers. Following completion of his PhD, Dr. Martínez-Pérez joined the Breast Cancer Now Edinburgh and Translational Oncology Research groups at the MRC Institute of Genetics and Molecular Medicine, led by Prof. Mike Dixon OBE and Dr. Arran Turnbull, as a postdoctoral researcher. His translational breast cancer research focuses on biomarker discovery and the development of novel diagnostic tools which could be of use to address current clinical needs. Projects to date have included a Breast Cancer Institute-funded study on ductal carcinoma in situ of the breast (DCIS) and work on a large international study of genomic aberrations linked to the development of resistance to treatment, supported by funding from Breast Cancer Now.